Uncategorized

Golden Triangle still dominates, but talent and capital gaps slow biotech growth

Golden Triangle still dominates, but talent and capital gaps slow biotech growth

Published

on

The U.K.’s core biotech cluster continues to produce world‑class science, but investors say limited talent mobility, uneven regional growth and tightening early‑ and mid‑stage capital are slowing the country’s ability to scale new companies.​ ​Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version